| [1] |
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion[J]. Fertil Steril, 2012, 98(5): 1103-1111.
|
| [2] |
DIMITRIADIS E, MENKHORST E, SAITO S, et al. Recurrent pregnancy loss[J]. Nat Rev Dis Primers, 2020, 6(1): 98.
|
| [3] |
CHRISTIANSEN O B. Special issue recurrent pregnancy loss: etiology, diagnosis, and therapy[J]. J Clin Med, 2021, 10(21): 5040.
|
| [4] |
RAI R, REGAN L. Recurrent miscarriage[J]. Lancet, 2006, 368(9535): 601-611.
|
| [5] |
LI J, CAO F, YIN H L, et al. Ferroptosis: past, present and future[J]. Cell Death Dis, 2020, 11(2): 88.
|
| [6] |
JIANG X J, STOCKWELL B R, CONRAD M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
|
| [7] |
LIU M, WU K M, WU Y K. The emerging role of ferroptosis in female reproductive disorders[J]. Biomed Pharmacother, 2023, 166: 115415.
|
| [8] |
CINDROVA-DAVIES T, SFERRUZZI-PERRI A N. Human placental development and function[J]. Semin Cell Dev Biol, 2022, 131: 66-77.
|
| [9] |
JI L, BRKIĆ J, LIU M, et al. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia[J]. Mol Aspects Med, 2013, 34(5): 981-1023.
|
| [10] |
XIAO Z Y, YAN L, LIANG X Y, et al. Progress in deciphering trophoblast cell differentiation during human placentation[J]. Curr Opin Cell Biol, 2020, 67: 86-91.
|
| [11] |
LUCAS E S, VRLJICAK P, MUTER J, et al. Recurrent pregnancy loss is associated with a pro-senescent decidual response during the peri-implantation window[J]. Commun Biol, 2020, 3(1): 37.
|
| [12] |
NORWITZ E R, SCHUST D J, FISHER S J. Implantation and the survival of early pregnancy[J]. N Engl J Med, 2001, 345(19): 1400-1408.
|
| [13] |
SANGKHAE V, NEMETH E. Placental iron transport: the mechanism and regulatory circuits[J]. Free Radic Biol Med, 2019, 133: 254-261.
|
| [14] |
ZAUGG J, SOLENTHALER F, ALBRECHT C. Materno-fetal iron transfer and the emerging role of ferroptosis pathways[J]. Biochem Pharmacol, 2022, 202: 115141.
|
| [15] |
CAO C, FLEMING M D. The placenta: the forgotten essential organ of iron transport[J]. Nutr Rev, 2016, 74(7): 421-431.
|
| [16] |
ZHANG Y J, LU Y, JIN L P. Iron metabolism and ferroptosis in physiological and pathological pregnancy[J]. Int J Mol Sci, 2022, 23(16): 9395.
|
| [17] |
BASTIN J, DRAKESMITH H, REES M, et al. Localisation of proteins of iron metabolism in the human placenta and liver[J]. Br J Haematol, 2006, 134(5): 532-543.
|
| [18] |
OTASEVIC V, VUCETIC M, GRIGOROV I, et al. Ferroptosis in different pathological contexts seen through the eyes of mitochondria[J]. Oxid Med Cell Longev, 2021, 2021: 5537330.
|
| [19] |
TIAN P, XU Z Y, GUO J R, et al. Hypoxia causes trophoblast cell ferroptosis to induce miscarriage through lnc-HZ06/HIF1α-SUMO/NCOA4 axis[J]. Redox Biol, 2024, 70: 103073.
|
| [20] |
HE Y B, HAN L, WANG C, et al. Bulk RNA-sequencing, single-cell RNA-sequencing analysis, and experimental validation reveal iron metabolism-related genes CISD2 and CYP17A1 are potential diagnostic markers for recurrent pregnancy loss[J]. Gene, 2024, 901: 148168.
|
| [21] |
ZHAO Y, ZHAO X X, FENG X L. Alpha-lipoic acid upregulates the PPARγ/NRF2/GPX4 signal pathway to inhibit ferroptosis in the pathogenesis of unexplained recurrent pregnancy loss[J]. Open Med (Wars), 2024, 19(1): 20240963.
|
| [22] |
GEORGIEFF M K, KREBS N F, CUSICK S E. The benefits and risks of iron supplementation in pregnancy and childhood[J]. Annu Rev Nutr, 2019, 39: 121-146.
|
| [23] |
DONOVAN A, LIMA C A, PINKUS J L, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis[J]. Cell Metab, 2005, 1(3): 191-200.
|
| [24] |
NG S W, LEE C, NG A, et al. Ferroportin expression and regulation in human placenta/fetal membranes: implications for ferroptosis and adverse pregnancy outcomes[J]. Reprod Biol, 2023, 23(4): 100816.
|
| [25] |
BEHARIER O, TYURIN V A, GOFF J P, et al. PLA2G6 guards placental trophoblasts against ferroptotic injury[J]. Proc Natl Acad Sci USA, 2020, 117(44): 27319-27328.
|
| [26] |
SUN F R, CUI L Y, QIAN J F, et al. Decidual stromal cell ferroptosis associated with abnormal iron metabolism is implicated in the pathogenesis of recurrent pregnancy loss[J]. Int J Mol Sci, 2023, 24(9): 7836.
|
| [27] |
CHEN X, LI J B, KANG R, et al. Ferroptosis: machinery and regulation[J]. Autophagy, 2021, 17(9): 2054-2081.
|
| [28] |
WANG B Q, WANG Y, ZHANG J, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis[J]. Arch Toxicol, 2023, 97(6): 1439-1451.
|
| [29] |
LEE J Y, KIM W K, BAE K H, et al. Lipid metabolism and ferroptosis[J]. Biology (Basel), 2021, 10(3): 184.
|
| [30] |
TANG D L, CHEN X, KANG R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2): 107-125.
|
| [31] |
BEHARIER O, KAJIWARA K, SADOVSKY Y. Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome[J]. Placenta, 2021, 108: 32-38.
|
| [32] |
SEIBT T M, PRONETH B, CONRAD M. Role of GPX4 in ferroptosis and its pharmacological implication[J]. Free Radic Biol Med, 2019, 133: 144-152.
|
| [33] |
LI F J, LONG H Z, ZHOU Z W, et al. System Xc-/GSH/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy[J]. Front Pharmacol, 2022, 13: 910292.
|
| [34] |
TANG D L, KROEMER G. Ferroptosis[J]. Curr Biol, 2020, 30(21): R1292-R1297.
|
| [35] |
WANG X Y, WEI Y C, WEI F Y, et al. Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases[J]. Front Cell Dev Biol, 2023, 11: 1146971.
|
| [36] |
LIU Z Z, TANG Y, ZHANG X Y, et al. Crosstalk between placental trophoblast and decidual immune cells in recurrent miscarriage[J]. Int J Med Sci, 2023, 20(9): 1174-1188.
|
| [37] |
CHEN L P, DAI F F, HUANG Y J, et al. Mechanisms of YAP1-mediated trophoblast ferroptosis in recurrent pregnancy loss[J]. J Assist Reprod Genet, 2024, 41(6): 1669-1685.
|
| [38] |
LI F, GUO L T, ZHOU M Q, et al. Cryptochrome 2 suppresses epithelial-mesenchymal transition by promoting trophoblastic ferroptosis in unexplained recurrent spontaneous abortion[J]. Am J Pathol, 2024, 194(7): 1197-1217.
|
| [39] |
GELLERSEN B, BROSENS J J. Cyclic decidualization of the human endometrium in reproductive health and failure[J]. Endocr Rev, 2014, 35(6): 851-905.
|
| [40] |
YANG X, WANG L J, WANG R F, et al. Homocysteine induces endometrial ferroptosis via MAPK pathway in recurrent pregnancy loss[J]. Placenta, 2025, 165: 148-161.
|
| [41] |
XING X Y, ZHANG G L, YI F J, et al. Overexpression of USP22 ameliorates LPS-induced endometrial stromal cells inflammation and modulates cells decidualization by inhibiting ferroptosis[J]. Reprod Biol, 2024, 24(3): 100913.
|
| [42] |
XU X, ZHU M W, ZU Y Z, et al. Nox2 inhibition reduces trophoblast ferroptosis in preeclampsia via the STAT3/GPX4 pathway[J]. Life Sci, 2024, 343: 122555.
|
| [43] |
YU S P, MU Y M, WANG K, et al. Gestational exposure to 1-NP induces ferroptosis in placental trophoblasts via CYP1B1/ERK signaling pathway leading to fetal growth restriction[J]. Chem Biol Interact, 2024, 387: 110812.
|
| [44] |
ZHU Y S, LU H, HUO Z H, et al. MicroRNA-16 inhibits feto-maternal angiogenesis and causes recurrent spontaneous abortion by targeting vascular endothelial growth factor[J]. Sci Rep, 2016, 6: 35536.
|
| [45] |
ZHANG Y, YANG Y, CHEN W N, et al. BaP/BPDE suppressed endothelial cell angiogenesis to induce miscarriage by promoting MARCHF1/GPX4-mediated ferroptosis[J]. Environ Int, 2023, 180: 108237.
|
| [46] |
SHANGGUAN M Y, ZHENG J Y, LIU N, et al. A preliminary study unveils CISD2 as a ferroptosis-related therapeutic target for recurrent spontaneous abortion through immunological analysis and two-sample mendelian randomization[J]. J Reprod Immunol, 2024, 163: 104249.
|
| [47] |
QIN C M, WU J Y, WEI X W, et al. ALKBH5 modulation of ferroptosis in recurrent miscarriage: implications in cytotrophoblast dysfunction[J]. PeerJ, 2024, 12: e18227.
|
| [48] |
LAI Y L, ZHANG Y, ZHANG H M, et al. Modified Shoutai Pill inhibited ferroptosis to alleviate recurrent pregnancy loss[J]. J Ethnopharmacol, 2024, 319(Pt 2): 117028.
|